DAPL1

Chr 2

death associated protein like 1

Predicted to enable ribosome binding activity; translation initiation factor binding activity; and translation repressor activity. Predicted to be involved in several processes, including negative regulation of CD8-positive, alpha-beta T cell activation; negative regulation of autophagy; and ribosome hibernation. Predicted to act upstream of or within cell population proliferation and gene expression. Predicted to be located in membrane. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jun 2026]

ResearchGenerating clinical summary…
0
Active trials
12
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
1.88
LOEUF
Multiple*
Mechanism· predicted
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.88LOEUF
pLI 0.000
Z-score -0.45
OE 1.22 (0.64–1.88)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.58Z-score
OE missense 1.22 (1.00–1.50)
65 obs / 53.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?1.22 (0.64–1.88)
0≤0.351.4
Missense OE?1.22 (1.00–1.50)
0≤0.61.4
Synonymous OE?1.18
0≤1.21.6
LoF obs/exp: 6 / 4.9Missense obs/exp: 65 / 53.1Syn Z: -0.61

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

DAPL1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →